Stereotaxis, Inc.STXS

NYSEHealthcareElectromedical & Electrotherapeutic Apparatus
Price (close)
$1.29
Market cap
$129.3M
P/E
—
Revenue (TTM)
$30.1M
Net income
-$22.3M
Dividend yield
—
1-year total return
-55.8%
Net margin
-74.2%
Revenue growth
-5.5%
Debt / equity
—

What Stereotaxis, Inc. does.

of Financial Condition and Results of Operations,” contains forward-looking statements. These statements relate to, among other

statements relate to future events or future financial performance, and involve known and unknown risks, uncertainties, and other factors

that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results,

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$26.6M$35.0M$28.1M$26.8M$26.9M$32.4M
Net income-$6.6M-$10.7M-$18.3M-$20.7M-$24.0M-$21.6M
Free cash flow-$3.6M-$4.3M-$10.8M-$9.5M-$8.5M-$13.8M

More on STXS.

Figures from Stereotaxis, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.